Compounds > 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone
Page last updated: 2024-08-23

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Diabetes Mellitus, Type 2

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, H; Al-Bayedh, SA; Qudsi, M; Rahim, MM; Roos, JF; Samara, A1

Reviews

1 review(s) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and Diabetes Mellitus, Type 2

ArticleYear
Metformin for lung cancer prevention and improved survival: a novel approach.
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2019, Volume: 28, Issue:4

    Topics: Carcinogenesis; Carcinogens; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Incidence; Lung; Lung Neoplasms; Metformin; Nicotiana; Nitrosamines; Signal Transduction; Smoke; Survival Analysis; Tobacco Smoking; TOR Serine-Threonine Kinases

2019